The effects of recombinant human thyrotropin, in normal subjects and patients with goitre.
Nielsen
Viveque Egsgaard
VE
Department of Endocrinology and Metabolism, Odense University Hospital and University of Southern Denmark, DK-5000 Odense, Denmark. viveque.egsgaard@ouh.fyns-amt.dk
Bonnema
Steen Joop
SJ
Hegedüs
Laszlo
L
D000818:Animals; D002417:Cattle; D003131:Combined Modality Therapy; D006044:Goiter, Nodular / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D013961:Thyroid Gland / Q000187:drug effects / Q000378:metabolism; D013972:Thyrotropin / Q000009:adverse effects / Q000627:therapeutic use*; D013974:Thyroxine / Q000378:metabolism
D007457:Iodine Radioisotopes; D011994:Recombinant Proteins; D013972:Thyrotropin; D013974:Thyroxine